The article sounds good, but when you dig deeper, there was disease progression in 93.5% of patients taking part in the trials and ony 6.5% achieved stable disease, with no full remissions. Still a step in the right direction.
The 50% or so 12 month survival is also hard to quantify without a control group.
Joined: Sep 2011
Thanks...
for posting this!
Ellen
Joined: Jan 2013
The article sounds good, but
The article sounds good, but when you dig deeper, there was disease progression in 93.5% of patients taking part in the trials and ony 6.5% achieved stable disease, with no full remissions. Still a step in the right direction.
The 50% or so 12 month survival is also hard to quantify without a control group.